The following information was mistakenly omitted from a recent article.1Steven Grover has conducted research supported by Pfizer, Bristol-Myers Squibb, Aventis and AstraZeneca. He has received consulting fees from Pfizer and AstraZeneca and speaker fees from Pfizer, Oryx and Aventis. He owns stock in Pfizer, Merck, Bristol-Myers Squibb and Kos.
Reference
- 1.↵